SILK - Silk Road Medical (SILK) Stock Tanks After Revenues Lowered and CEO Leaves – Hagens Berman Firm Encourages Investors with Substantial Losses to Contact its Attorneys | Benzinga
SAN FRANCISCO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ:SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws.
| Visit: www.hbsslaw.com/investor-fraud/SILK |
| Contact An Attorney Now: |
| SILK@hbsslaw.com |
| 844-916-0895 |
Silk Road Medical, Inc. (NASDAQ:SILK) Investigation:
The investigation focuses on Silk Road's statements concerning financial risks to its business posed by the Centers for Medicare & Medicaid Services' ("CMS") July 2023 proposed National Coverage Determination ("NCD").
The NCD reportedly proposed to change coverage for a stroke treatment for carotid artery disease ("CAD") that could put a competing therapy alongside Silk Road's Transcarotid Artery Revascularization ("TCAR") therapy regarding reimbursement.
On Oct. 10, 2023, Silk Road ...
SILK) Stock Tanks After Revenues Lowered and CEO Leaves – Hagens Berman Firm Encourages Investors with Substantial Losses to Contact its Attorneys>Full story available on Benzinga.com